Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum
- PMID: 20145263
- PMCID: PMC2940977
- DOI: 10.1177/0091270009358708
Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum
Abstract
The objectives were to evaluate the time course for atenolol pharmacokinetics in lactating women postpartum and to quantify atenolol plasma concentrations in the women's 3- to 4-month-old nursing infants. Data were collected during 1 dosing interval from lactating women treated with atenolol for therapeutic reasons, at 2 to 4 weeks (n = 32), 3 to 4 months (n = 22), and 6 to 8 months (n = 17) postpartum. A single blood sample was collected from 15 nursing infants (3-4 months of age) of the mothers participating in the study. At 2 to 4 weeks, 3 to 4 months, and 6 to 8 months postpartum, atenolol infant doses, relative to the mother's weight-adjusted dose, were 14.6% ± 7.6%, 8.3% ± 5.2% and 5.9% ± 2.9%, respectively. Over this time, maternal atenolol pharmacokinetics did not change to a clinically significant extent. Atenolol concentrations were below assay quantification limits (<10 ng/mL) in the plasma of all 3- to 4-month-old nursing infants studied. These findings support the careful use of atenolol during breastfeeding, because in the vast majority of healthy, term infants, atenolol concentrations will be too low to be clinically relevant. Premature infants and those with kidney disease require further study. Infant exposure depends on maternal dose and decreases during the first 6 to 8 months postpartum.
Figures



Similar articles
-
Estimation of Atenolol Transfer Into Milk and Infant Exposure During Its Use in Lactating Women.J Hum Lact. 2018 Aug;34(3):592-599. doi: 10.1177/0890334418771308. Epub 2018 Jun 5. J Hum Lact. 2018. PMID: 29870669
-
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.Pediatrics. 2003 Nov;112(5):e425. doi: 10.1542/peds.112.5.e425. Pediatrics. 2003. PMID: 14595087
-
Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.PLoS Med. 2016 Sep 27;13(9):e1002132. doi: 10.1371/journal.pmed.1002132. eCollection 2016 Sep. PLoS Med. 2016. PMID: 27676257 Free PMC article.
-
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.Cochrane Database Syst Rev. 2020 May 18;5(5):CD011505. doi: 10.1002/14651858.CD011505.pub2. Cochrane Database Syst Rev. 2020. PMID: 32421208 Free PMC article.
-
The effect of lactation on ovulation and fertility.Clin Perinatol. 1987 Mar;14(1):39-50. Clin Perinatol. 1987. PMID: 3549114 Review.
Cited by
-
A tutorial on physiologically based pharmacokinetic approaches in lactation research.CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1841-1855. doi: 10.1002/psp4.13232. Epub 2024 Sep 16. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39283747 Free PMC article.
-
Design Considerations for Pharmacokinetic Studies During Pregnancy.J Clin Pharmacol. 2023 Jun;63 Suppl 1(Suppl 1):S126-S136. doi: 10.1002/jcph.2238. J Clin Pharmacol. 2023. PMID: 37317491 Free PMC article.
-
Basic obstetric pharmacology.Semin Perinatol. 2014 Dec;38(8):475-86. doi: 10.1053/j.semperi.2014.08.011. Epub 2014 Oct 1. Semin Perinatol. 2014. PMID: 25281357 Free PMC article. Review.
-
Transporters and drug secretion into human breast milk.Expert Opin Drug Metab Toxicol. 2025 Apr;21(4):409-428. doi: 10.1080/17425255.2025.2461479. Epub 2025 Feb 7. Expert Opin Drug Metab Toxicol. 2025. PMID: 39893560 Review.
-
Breastfeeding and migraine drugs.Eur J Clin Pharmacol. 2014 Nov;70(11):1313-24. doi: 10.1007/s00228-014-1748-0. Epub 2014 Sep 13. Eur J Clin Pharmacol. 2014. PMID: 25217187 Review.
References
-
- American Academy of Pediatrics, Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776–779. - PubMed
-
- TenorminR product labeling. AstraZeneca; Wilmington DE: Apr 08, 2008.
-
- Schmimmel MS, Eidelman AJ, Wilschanski MA, Shaw D, Ogilvie RJ, Koren G. Toxic effects of atenolol consumed during breast feeding. J Pediatr. 1989;114:476–478. - PubMed
-
- Fowler MB, Brudenell M, Jackson G, Holt DW. Essential hypertension and pregnancy: successful outcome with atenolol. Br J Clin Pract. 1984;38:73–74. - PubMed
-
- White WB, Andreoli JW, Wong SH, Cohn RD. Atenolol in human plasma and breast milk. Obstet Gynecol. 1984;63(3 Suppl):42S–44S. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical